Gossamer Bio vs Q32 Bio
Q32 Bio reported revenue of $54 million in fiscal 2025, about the same as Gossamer Bio's $48 million in fiscal 2025. Gossamer Bio had an operating margin of -352.2%, against 31.4% at Q32 Bio. Free cash flow was −$171 million at Gossamer Bio and −$34 million at Q32 Bio.
Side by side
| Gossamer Bio | Q32 Bio | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $48M | $54M |
| Revenue growth | −57.7% | — |
| Revenue growth a year, last 5 years | — | 81.9% |
| Gross margin | — | — |
| Operating margin | −352.2% | 31.4% |
| Net margin | −351.5% | 55.5% |
| Free cash flow | −$171M | −$34M |
| Free cash flow margin | −353.5% | −62.4% |
| Return on capital | — | — |
| Net debt to EBITDA | — | −2.8x |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 1.0% | 27.5% |
| Last close | $11.23 | $8.48 |
| P/E at the last close | — | 10.5× |
| Insider trades, last 12 months | — | — |
| Piotroski F-score | 0 of 8 | 3 of 8 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Gossamer BioQ32 Bio
Operating margin
Percent of revenue
Gossamer BioQ32 Bio
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Gossamer BioQ32 Bio
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Gossamer Bio and Q32 Bio pages.